author-photo

Ivor Royston

Cardiff University

5

Papers

2

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Oral Nanatinostat (Nstat) and Valganciclovir (VGCV) in Patients with Recurrent Epstein-Barr Virus (EBV)-Positive Lymphomas: Initial Phase 2 Results

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
A phase Ib/II study of oral nanatinostat (N) and valganciclovir (VG) in subjects with Epstein-Barr virus (EBV)-associated lymphomas.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (2)
Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study

2019 Blood
Show All
- Source
- Cite
- Save
Citations (0)